Alector Valuation
| ALEC Stock | USD 1.91 0.04 2.05% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Alector shows a prevailing Real Value of $1.73 per share. The current price of the firm is $1.91. Our model approximates the value of Alector from analyzing the firm fundamentals such as return on equity of -1.22, and Profit Margin of (1.56) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Alector's price fluctuation is very risky at this time. Calculation of the real value of Alector is based on 3 months time horizon. Increasing Alector's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Alector is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alector Stock. However, Alector's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.91 | Real 1.73 | Hype 1.91 |
The real value of Alector Stock, also known as its intrinsic value, is the underlying worth of Alector Company, which is reflected in its stock price. It is based on Alector's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Alector's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Alector helps investors to forecast how Alector stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alector more accurately as focusing exclusively on Alector's fundamentals will not take into account other important factors: About Alector Valuation
The stock valuation mechanism determines Alector's current worth on a weekly basis. Our valuation model uses a comparative analysis of Alector. We calculate exposure to Alector's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Alector's related companies.Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. The company was founded in 2013 and is headquartered in South San Francisco, California. Alector operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 269 people.
Alector Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 96.6 M | |
| Quarterly Earnings Growth Y O Y | -0.863 | |
| Forward Price Earnings | 8.4674 |
Complementary Tools for Alector Stock analysis
When running Alector's price analysis, check to measure Alector's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alector is operating at the current time. Most of Alector's value examination focuses on studying past and present price action to predict the probability of Alector's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alector's price. Additionally, you may evaluate how the addition of Alector to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |